![Maggie Shafmaster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maggie Shafmaster
Direktor/Vorstandsmitglied bei
PROMIS NEUROSCIENCES, INC.
Vermögen: 4 Mio $ am 31.05.2026
Profil
Maggie Shafmaster currently works at ProMIS Neurosciences, Inc., as Lead Independent Director from 2021.
Dr. Shafmaster also formerly worked at Genzyme Corp., as Chief Patent Counsel & Senior Vice President and Sanofi Pasteur Ltd., as Chief Patent Counsel & Vice President.
Dr. Shafmaster received her graduate degree from New York Law School, undergraduate degree from the University of California, and doctorate degree from Cornell University Graduate School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.05.2026 | 345.380 ( 3,85 % ) | 4 Mio $ | 31.05.2026 |
Aktive Positionen von Maggie Shafmaster
| Unternehmen | Position | Beginn |
|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Direktor/Vorstandsmitglied | 22.09.2021 |
Ehemalige bekannte Positionen von Maggie Shafmaster
| Unternehmen | Position | Ende |
|---|---|---|
Sanofi Pasteur Ltd.
 Sanofi Pasteur Ltd. BiotechnologyHealth Technology Develops, manufactures and markets vaccines and immunotherapeutic products | Corporate Officer/Principal | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Ausbildung von Maggie Shafmaster
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
8
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
ProMIS Neurosciences, Inc.
 ProMIS Neurosciences, Inc. BiotechnologyHealth Technology Discovers and develops precision medicine solutions for the treatment of neurodegenerative & misfolded protein diseases | Health Technology |
Sanofi Pasteur Ltd.
Sanofi Pasteur Ltd. BiotechnologyHealth Technology Develops, manufactures and markets vaccines and immunotherapeutic products | Health Technology |
New York Law School
 New York Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University Graduate School
 Cornell University Graduate School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
